Cansartan-Mepha plus 16/12.5, Tabletten - 98 Tablette(n) Swissmedic Key 61215008 Registration Holder Mepha Pharma AG Name Cansartan-Mepha plus 16/12.5, Tabletten Date of registration 24.01.2011 Original/Generic Generic Introduction of Sequence 24.01.2011 ATC-Classification Candesartan and Diuretics (C09DA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.20. Show package size 98 Tablette(n) Index Therapeuticus (Swissmedic) 02.07.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 31.45 Limitation No Deductible 10 % Consumer price 50.70 Feedback FB GTIN 7680612150084 Medication Code Synthetika Pharmacode 5431383 Disponibility
Composition candesartanum cilexetilum 16.00 mg, hydrochlorothiazidum 12.50 mg, maydis amylum, lactosum monohydricum 109.30 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.43 mg, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 16 mg Hydrochlorothiazide 12.5 mg
BAG: Active Agent Dose Candesartanum Cilexetil 16 mg Hydrochlorothiazide 12.5 mg
Inactive agents Dose Carmellosum Natricum Conexum Hydroxypropylcellulosum Lactose Monohydrate 109.3 mg Magnesii Stearas Maydis Amylum Pro Compresso Triethylis Citras
Source Data was imported : 12.05.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
